DexCom (DXCM) Accused of Misleading Investors About Sales Force Changes and Financial Outlook - Hagens Berman
SAN FRANCISCO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM), alleging that the medical device company made misleading statements about its financial performance and growth prospects. Hagens …